427 Efficacy and safety of AK112, an anti-PD-1/VEGF-A bispecific antibody, in patients with platinum-resistant/refractory epithelial ovarian cancer in a Phase 1 study
oleh: Yu Xia, Charlotte Lemech, Xiaoping Jin, Jermaine Coward, Anna Mislang, Baiyong Li, Kon Yew Kwek, Yiting Zhou, Max Wang
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2021-11-01 |
Deskripsi
No description available for this item.